Cost-effectiveness of cyclophosphamide and non-cyclophosphamide in the induction therapy of Malaysian lupus nephritis patients

Background There is a paradigm shift in the induction therapy for proliferative lupus nephritis (LN). Apart from cyclophosphamide (CYC), mycophenolate mofetil and calcineurin inhibitors have emerged as an alternative option of treatment. Objective We aimed to compare the cost-effectiveness analysis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lupus 2022-08, Vol.31 (9), p.1138-1146
Hauptverfasser:	Rosli, Fatimah Z, Shaharir, Syahrul S, Abdul Gafor, Abdul H, Mohd, Rozita, Aizuddin, Azimatun N, Osman, Sabrizan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Biopsy Calcineurin Calcineurin inhibitors Capital costs Cost analysis Cyclophosphamide Induction therapy Kidneys Lupus Lupus nephritis Medical records Mycophenolate mofetil Mycophenolic acid Nephritis Patients Remission
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!